简介：
Overview
This article presents a protocol for differentiating human induced pluripotent stem cells (iPSCs) into somite derivatives, including myotome, sclerotome, dermatome, and syndetome, under chemically defined conditions. This method has significant implications for disease modeling and cell-based therapies in orthopedic surgery.
Key Study Components
Area of Science
- Stem Cell Biology
- Regenerative Medicine
- Orthopedic Surgery
Background
- Induced pluripotent stem cells (iPSCs) can differentiate into various cell types.
- Understanding somite derivatives is crucial for regenerative therapies.
- This study focuses on the differentiation of iPSCs into specific somite derivatives.
- The protocol aims to enhance disease modeling and therapeutic applications.
Purpose of Study
- To develop a reliable method for differentiating iPSCs into somite derivatives.
- To model musculoskeletal disorders using patient-derived iPSCs.
- To investigate the mechanisms of paraxial mesoderm development.
Methods Used
- Coating culture dishes with extracellular matrix for cell adhesion.
- Using feeder-free culture conditions for iPSC maintenance.
- Inducing presomitic mesoderm differentiation with specific media.
- Isolating and characterizing differentiated cell populations via flow cytometry and immunocytochemistry.
Main Results
- Over 85% of cells expressed delta-like protein 1 after differentiation.
- Cells transitioned from delta-like protein 1 positive to PAX3 positive during somitic mesoderm induction.
- iPSC-derived dermatome cells produced collagen and hyaluronic acid.
- Successful differentiation towards various somite derivatives was achieved.
Conclusions
- The protocol enables effective differentiation of iPSCs into somite derivatives.
- This method can facilitate the study of musculoskeletal disorders.
- Future applications may include novel cell-based therapies.
What are somite derivatives?
Somite derivatives include myotome, sclerotome, dermatome, and syndetome, which are essential for muscle and skeletal development.
How does this protocol benefit disease modeling?
It allows researchers to use patient-derived iPSCs to model specific musculoskeletal disorders and test new therapies.
What is the significance of delta-like protein 1?
Delta-like protein 1 is a marker for presomitic mesoderm, indicating successful differentiation of iPSCs.
Can this method be applied to other types of stem cells?
While this protocol focuses on iPSCs, similar methods may be adapted for other stem cell types.
What role does the ROCK inhibitor play in the protocol?
The ROCK inhibitor is used to enhance cell survival and promote differentiation during the culture process.
How long does the differentiation process take?
The entire differentiation process spans several days, with specific media changes at designated intervals.
繁體中文
